Multiple Myeloma

>

The OncLive Multiple Myeloma condition center page is a comprehensive resource for clinical news and expert insights on multiple myeloma and how to treat patients with monoclonal antibodies, proteasome inhibitors, bispecific T-cell engagers, immunomodulatory agents, CAR T-cell therapy, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in multiple myeloma.

Latest News

Angela Dispenzieri, MD
Smoldering Multiple Myeloma Management Hinges on the Debate Between Treatment and Observation

September 25th 2023

The smoldering multiple myeloma treatment paradigm harbors fractures in the consensus regarding the optimal management of this disease, with some experts favoring a watch-and-wait approach and others advocating for early treatment.

Ajai Chari, MD
Novel Targets Could Expand CAR T-Cell Therapy and Bispecific Antibody Options in Myeloma

September 22nd 2023

FDA Grants Orphan Drug Designation to NXC-201 for AL Amyloidosis
FDA Grants Orphan Drug Designation to NXC-201 for AL Amyloidosis

September 21st 2023

Multiple Myeloma
CHMP Recommends Against Renewal of Marketing Authorization for Belantamab Mafodotin in R/R Myeloma

September 18th 2023

The European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion regarding a Type II variation application to extend the therapeutic indication of melphalan flufenamide for use in adult patients with multiple myeloma who have received at least 2 prior lines of treatment and whose disease is refractory to lenalidomide and the last line of therapy.
Extended Melphalan Flufenamide Indication Approaches EU Approval for R/R Multiple Myeloma

September 14th 2023

Latest CME Events & Activities

25th Annual International Lung Cancer Congress®

Register Now!

BURST CME™: Utilizing Pathology Reports to Inform Treatment Plans Across GI Cancers

View More

Advances In™: Meeting Unmet Clinical Needs in AML with Evolving Therapeutic Approaches

View More

Bridging the Care Gap in Anemia in CKD: A Comprehensive Guide to Enhancing Patient Care

Register Now!

Antibody-Drug Conjugates in Gynecological Cancer – Setting the Stage

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

2022 BURST Year in Review™: Reflecting on Recent Evidence for Testing in Patients with GI Cancers

View More

2nd Annual International Congress on Pediatric Oncology

View More

2022 BURST Year in Review™: How Has Recent Evidence in Testing Elevated Outcomes in Patients with Lung Cancers

View More

4th Annual Virtual Tumor Board®: Diagnosis and Management of Polycythemia Vera and Myelofibrosis

View More

Burst CME: Regulatory Approval Pathways for Influenza Vaccines

View More

Community Practice Connections™: 23rd Annual International Lung Cancer Congress®

View More

Medical Crossfire®: Experts Address Your Burning Questions on the Evolving Treatment of MF, PV, and ET!

View More

Oncology Consultations®: Leveraging Clinical Data and Trials to Inform Treatment for Patients with PV

View More

Clinical Interchange™: Improving Outcomes and Overcoming Barriers to Equitable Care in African American Patients With Multiple Myeloma

View More

How CEACAM5 Expression Can Be Measured and Leveraged in NSCLC Care: Current Developments & Future Therapeutic Opportunities

Register Now!

PER's Breast Cancer Symposia in San Antonio

Register Now!

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

Register Now!

Oncology Town Hall™: Primary Investigators Present Key Abstracts in the Management of CLL

View More

Updates from the Annual Hematology Meeting: Matching the Tumor with Patient Specific Goals to Inform Frontline Selection and Sequencing in Chronic Lymphocytic Leukemia

View More

Bridging Clinical Gaps in Indolent and Aggressive B-Cell Lymphomas: The Investigators Demonstrate How Novel Mechanisms Will Impact Your Practice Tomorrow

View More

Follicular Lymphoma Workshop: Forging Patient-Centric Plans with Targeted Therapies Across Lines of Care

View More

State-of-the-Art CMV Care: Experts’ Perspectives on Primary/Secondary Prevention and Management of Refractory/Resistant Infections

View More

Cancer Summaries and Commentaries™: Report from New Orleans on the Latest Updates in the Treatment of MPNs

View More

Medical Crossfire®: How Do We Apply the Latest Evidence on Novel Therapies to Prevent and Treat GVHD?

View More

Medical Crossfire®: How The Experts Treat Acute Lymphoblastic Leukemia: Case Discussions from Adolescent to Adult

View More

"D" is for Diagnosis: Deciphering Uncommon Hematologic Disorders Through the Eyes of a Detective

View More

MRD Assessment as a Cornerstone to Clinical Decision-Making in Hematologic Malignancies: Techniques, Utilization, and Best Practices to Optimize Patient Outcomes

View More

Community Practice Connections™: How We Do It: Application of State-of-the-Art MF and PV Care Today… With An Eye Toward How New Evidence and Combinations Will be Leveraged Tomorrow

View More

BURST CME™: Addressing Current Standards and Unmet Needs in Patients with Metastatic Breast Cancer

View More

More News